Accordingly, we used this approach to investigate the effect of loss of SMN sumoylation in mouse models of SMA as a means to uncover which and how downstream events disrupted by SMN deficiency contribute to the disease phenotype. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.